Actively Recruiting
Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation
Led by Technische Universität Dresden · Updated on 2025-07-02
76
Participants Needed
12
Research Sites
241 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
maintenance of AML or MDS patients with known IDH1 mutation after allogeneic stem cell transplantation within past 100 days
CONDITIONS
Official Title
Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Acute Myeloid Leukemia (AML) or Myelodysplastic Neoplasia (MDS) with an IDH1 mutation
You will not qualify if you...
- Active graft versus host disease (GvHD) grade III-IV requiring steroids greater than 1 mg/kg prednisolone equivalent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 12 locations
1
Universitätsklinikum Aachen
Aachen, Germany
Not Yet Recruiting
2
Technische Universitaet Dresden, Medizinische Klinik und Poliklinik I
Dresden, Germany
Not Yet Recruiting
3
Universitätsklinikum Essen
Essen, Germany
Not Yet Recruiting
4
Martin-Luther-Universitaet Halle-Wittenberg
Halle, Germany
Actively Recruiting
5
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
Not Yet Recruiting
6
Universitätsklinikum Jena
Jena, Germany
Not Yet Recruiting
7
Universitätsklinikum Schleswig-Holstein
Kiel, Germany
Actively Recruiting
8
Universität Leipzig
Leipzig, Germany
Not Yet Recruiting
9
Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)
München, Germany
Not Yet Recruiting
10
Universität Münster
Münster, Germany
Not Yet Recruiting
11
Rostock University Medical Center
Rostock, Germany
Not Yet Recruiting
12
Universitaetsklinikum Ulm
Ulm, Germany
Not Yet Recruiting
Research Team
J
Jan Moritz Middeke, Dr. med.
CONTACT
F
Friedrich Stölzel, Prof. Dr. med.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here